REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Recruiting now

Conditions studied: Aortic Stenosis

In brief

The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).

Key facts

Study ID
NCT06777368
Run by
Medtronic Cardiovascular
People needed
225
Starts
2025-02-06
Expected to finish
2027-11-01
Last updated by the study team
2026-05-28

Who can join

Age: 18 and older, up to 105. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.